MAPT and Alzheimer disease: For example, Aβ42/Aβ40 ratio (Doecke et al., 2020) and phosphorylated tau p-Thr181 tau (Thijssen et al., 2020) and p-Thr205 tau (Barthélemy et al., 2020)) can be used to assist the diagnosis and prognosis of AD.